DK0961611T3 - Ekspanderbart gastroretentivt terapeutisk system med kontrolleret frisætning af aktivt stof i den gastrointestinale kanal - Google Patents

Ekspanderbart gastroretentivt terapeutisk system med kontrolleret frisætning af aktivt stof i den gastrointestinale kanal

Info

Publication number
DK0961611T3
DK0961611T3 DK98906865T DK98906865T DK0961611T3 DK 0961611 T3 DK0961611 T3 DK 0961611T3 DK 98906865 T DK98906865 T DK 98906865T DK 98906865 T DK98906865 T DK 98906865T DK 0961611 T3 DK0961611 T3 DK 0961611T3
Authority
DK
Denmark
Prior art keywords
gastrointestinal
controlled release
expandable
active substance
therapeutic system
Prior art date
Application number
DK98906865T
Other languages
English (en)
Inventor
Bodo Asmussen
Karsten Cremer
Hans-Rainer Hoffmann
Karin Ludwig
Michael Roreger
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK0961611T3 publication Critical patent/DK0961611T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009Sachets, pouches characterised by the material or function of the envelope
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
DK98906865T 1997-01-14 1998-01-09 Ekspanderbart gastroretentivt terapeutisk system med kontrolleret frisætning af aktivt stof i den gastrointestinale kanal DK0961611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19700915 1997-01-14
PCT/EP1998/000099 WO1998031341A1 (de) 1997-01-14 1998-01-09 Expandierbares gastroretentives therapie-system mit kontrollierter wirkstofffreisetzung im gastrointestinaltrakt

Publications (1)

Publication Number Publication Date
DK0961611T3 true DK0961611T3 (da) 2002-07-15

Family

ID=7817288

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98906865T DK0961611T3 (da) 1997-01-14 1998-01-09 Ekspanderbart gastroretentivt terapeutisk system med kontrolleret frisætning af aktivt stof i den gastrointestinale kanal

Country Status (20)

Country Link
US (1) US6290989B1 (da)
EP (1) EP0961611B1 (da)
JP (1) JP3825811B2 (da)
KR (1) KR100503266B1 (da)
AT (1) ATE214916T1 (da)
AU (1) AU727753B2 (da)
CA (1) CA2277277C (da)
CZ (1) CZ297098B6 (da)
DE (2) DE19800523C2 (da)
DK (1) DK0961611T3 (da)
ES (1) ES2175676T3 (da)
HU (1) HU224224B1 (da)
ID (1) ID22698A (da)
IL (1) IL130872A (da)
NO (1) NO993383D0 (da)
NZ (1) NZ336691A (da)
PL (1) PL193282B1 (da)
PT (1) PT961611E (da)
SK (1) SK93999A3 (da)
WO (1) WO1998031341A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822278A1 (de) * 1998-05-18 1999-12-02 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoff im Gastrointestinaltrakt mit verzögerter Pyloruspassage
DE19837073A1 (de) * 1998-08-17 2000-03-23 Lohmann Therapie Syst Lts Folienförmige Wirkstoffträger
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
DE19850309A1 (de) * 1998-10-30 2000-05-04 Lohmann Therapie Syst Lts Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer
DE19920833A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System mit quellbaren Polymeren
DE19920838A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System mit Kapillaren
DE19920854A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Verfahren und Vorrichtung zum Herstellen eines gastroretentiven flachen Schlauchbeutels mit Längsnaht
DE19920837A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System für verlängerte Verweilzeit im Magen bzw. im Gastrointestinaltrakt
DE19920855A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Magenvolumenreduzierende Darreichungsform
MXPA02007254A (es) 2000-02-04 2002-12-09 Depomed Inc Forma de dosis de cubierta-y-nucleo que se aproxima a liberacion de droga de orden cero.
GB0102725D0 (en) * 2001-02-02 2001-03-21 Stowic Resources Ltd Medical delivery system
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
WO2003051329A1 (de) * 2001-12-17 2003-06-26 Beisel Guenther Mittel zur oralen einnahme und verfahren zu dessen herstellung
US6869333B2 (en) * 2002-09-11 2005-03-22 National Optronics, Inc. Lens blank alignment and blocking device and method
US20040180086A1 (en) * 2002-10-11 2004-09-16 Zebunnissa Ramtoola Gastro-retentive levodopa delivery form
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
CA2574912A1 (en) * 2004-07-30 2006-02-02 Merrion Research Ii Limited Improved process and machine for automated manufacture of gastro-retentive devices
US8852083B2 (en) * 2005-02-04 2014-10-07 Uti Limited Partnership Self-stabilized encapsulated imaging system
KR100822519B1 (ko) * 2005-02-15 2008-04-16 주식회사종근당 위장 내에서 제어방출되는 단일 매트릭스 정제
CA2675230A1 (en) * 2006-01-10 2008-07-26 Pipex, Inc. Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases
US9579227B2 (en) * 2006-03-29 2017-02-28 Eat Little Inc. Ingestible implement for weight control
EP2004106B1 (en) * 2006-03-29 2012-05-30 Eatlittle Inc. Ingestible implement for weight control
WO2008074153A1 (en) * 2006-12-18 2008-06-26 Electronic Dietary Foods Inc. Device for delivery of a substance
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
US20120321706A1 (en) * 2009-10-19 2012-12-20 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
US20140343452A1 (en) * 2011-12-21 2014-11-20 Eatlittle Inc. Pseudobezoar-Based Intraluminal Gastrointestinal Cleansing and Biospy
AU2021396978A1 (en) 2020-12-08 2023-02-23 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
DE3400106A1 (de) 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
EP0283474A1 (de) * 1985-10-09 1988-09-28 Desitin Arzneimittel GmbH Verfahren zur herstellung einer darreichungs- und dosierungsform für arzneimittelwirkstoffe, reagentien oder andere wirkstoffe
IL87710A (en) * 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
DE3812799A1 (de) 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
WO1993012765A1 (en) * 1991-12-27 1993-07-08 Merck & Co., Inc. A controlled release drug dispersion delivery device
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen

Also Published As

Publication number Publication date
JP3825811B2 (ja) 2006-09-27
ATE214916T1 (de) 2002-04-15
CZ297098B6 (cs) 2006-09-13
JP2001508068A (ja) 2001-06-19
ID22698A (id) 1999-12-09
IL130872A (en) 2004-02-19
CZ249599A3 (cs) 2000-01-12
HU224224B1 (hu) 2005-06-28
IL130872A0 (en) 2001-01-28
PL193282B1 (pl) 2007-01-31
WO1998031341A1 (de) 1998-07-23
DE19800523C2 (de) 1999-01-21
ES2175676T3 (es) 2002-11-16
PL334834A1 (en) 2000-03-27
AU6292298A (en) 1998-08-07
KR20000070179A (ko) 2000-11-25
HUP0000943A3 (en) 2000-11-28
CA2277277C (en) 2005-03-08
EP0961611A2 (de) 1999-12-08
PT961611E (pt) 2002-09-30
NO993383L (no) 1999-07-08
EP0961611B1 (de) 2002-03-27
NZ336691A (en) 2000-05-26
NO993383D0 (no) 1999-07-08
CA2277277A1 (en) 1998-07-23
HUP0000943A2 (hu) 2000-10-28
KR100503266B1 (ko) 2005-07-25
DE59803511D1 (de) 2002-05-02
SK93999A3 (en) 2000-01-18
DE19800523A1 (de) 1998-07-30
US6290989B1 (en) 2001-09-18
AU727753B2 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
DK0961611T3 (da) Ekspanderbart gastroretentivt terapeutisk system med kontrolleret frisætning af aktivt stof i den gastrointestinale kanal
CA2344672A1 (en) Expandable gastroretentive therapy system having a prolonged gastric residence time
DK0914119T3 (da) Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan
AU6872201A (en) Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
NO995753L (no) Gastroretarderende mikrosfærer med styrt frigivelse for bedret administrasjon av medikament
DK0572486T3 (da) Orale dosisformer med forsinket frigivelse til behandling af tarmforstyrrelser
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
NO996352D0 (no) <Kappa>-antagenist-forbindelser, farmasoeytiske sammensetninger og fremgangsmåte for forebygging og behandling av pruritus
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
DE60123384D1 (de) Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
TR199802139T2 (xx) Sisaprid'in an�nda tahliye sa�layan, PH'dan ba��ms�z kat� dozaj �ekli.
NO20020976D0 (no) Retarderte, orale, farmasöytiske administreringsformer
NO20002721L (no) Heterocykliske forbindelser for inhibering av mavesyresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
BR9912979B1 (pt) composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
BR0012981A (pt) Sistema para liberação oral de droga hidrodinamicamente balanceado
DK1140031T3 (da) Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stof
GT200100033A (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina.
NO913019L (no) Faste orale preparatformer som inneholder ifosfamid som virksomt stoff.
DK1071397T3 (da) Levosimendan-holdige lægemidler til oral indgivelse med kontrolleret frisætning af det aktive middel
DK0768882T3 (da) Carbamazepin-lægemiddelform med forsinket aktivmiddelfrigivelse
NO980384D0 (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler
WO2003037301A3 (en) Oral dosage forms for improving the bioavailability of therapeutic agents
DK0979069T3 (da) Fremgangsmåde til fremstilling af peroralt anvendelige faste lægemiddelformer med styret afgivelse af aktivt stof
DK1003476T3 (da) Doseringsform med langvarig afgivelse af aktivt middel, der er indrettet til gastrisk retention